References
- Al-Yahyaee SA, Al-Kindi MN, Al-Bahrani AI. Apolipoprotein A1 gene polymorphisms at the −75 bp and +83/84 bp polymorphic sites in healthy Omanis compared with world populations. Hum Biol 2004; 76: 307–312
- Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res 2006; 124: 235–244
- Heng CK, Low PS, Saha N. Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein(a) levels in Asian Indian neonates from Singapore. Pediatr Res 2001; 49: 514–518
- Hughes K, Lun KC, Yeo PP. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. Differences in mortality. J Epidemiol Comm Health 1990; 44: 24–28
- Jeenah M, Kessling A, Miller N, Humphries SE. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med 1990; 7: 233–241
- Lahoz C, Peña R, Mostaza JM, Jiménez J, Subirats E, Pintó X, Taboada M, López-Pastor A, Study Group RAP. Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy. Atherosclerosis 2003; 168: 289–295
- Machado MO, Hirata MH, Bertolami MC, Hirata RD. Apo B gene haplotype is associated with lipid profile of higher risk for coronary heart disease in Caucasian Brazilian men. J Clin Lab Anal 2001; 15: 19–24
- Pan JP, Chiang AN, Tai JJ, Wang SP, Chang MS. Restriction fragment length polymorphisms of apolipoprotein B gene in Chinese population with coronary heart disease. Clin Chem 1995; 41: 424–429
- Puri RD, Tewari S, Sinha N, Ramesh V, Khan F, Singh VP, Agrawal S.. Polymorphisms in the apolipoprotein B-100 gene: Association with plasma lipid concentration and coronary artery disease. Indian Heart J 2003; 55: 60–64
- Saha N, Tay JS, Heng CK, Humphries SE. DNA polymorphisms of the apolipoprotein B gene are associated with obesity and serum lipids in healthy Indians in Singapore. Clin Genet 1993; 44: 113–120
- Wang XL, Liu SX, McCredie RM, Wilcken DE. Polymorphisms at the 5′-end of the apolipoprotein AI gene and severity of coronary artery disease. J Clin Invest 1996a; 98: 372–377
- Wang XL, Badenhop R, Humphrey KE, Wilcken DE. New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: Association with increased circulating high density lipoprotein cholesterol levels. Genet Epidemiol 1996b; 13: 1–10